Equity Capital Markets

Company · CIK 1826457

Monte Rosa Therapeutics, Inc.

CIK1826457 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressMA
ListedGLUE (Nasdaq)
First annual or quarterly report2021-08-12

Offerings

4 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-293389
ShelfEffective
 2026-02-112026-02-111
333-285942
ShelfEffective
 2025-03-202026-01-094
333-266003
ShelfEffective
 2022-07-012024-05-165
333-256773
IPOFinal prospectus
 2021-06-042021-06-255

Filings

16
FiledFilingRegistrationAccession
2026-02-11S-3ASRShelf registered 333-2933890001193125-26-046690
2026-01-09424B5Shelf takedown 333-2859420001193125-26-009001
2026-01-07424B5Shelf takedown 333-2859420001193125-26-006297
2025-03-31EFFECTDeclared effective 333-2859429999999995-25-000901
2025-03-20S-3Shelf registered 333-2859420001193125-25-058423
2024-05-16424B5Shelf takedown 333-2660030001193125-24-140518
2024-05-15424B5Shelf takedown 333-2660030001193125-24-139354
2023-10-26424B5Shelf takedown 333-2660030001193125-23-264155
2022-07-13EFFECTDeclared effective 333-2660039999999995-22-002061
2022-07-01S-3Shelf registered 333-2660030001193125-22-187284
2021-06-25424B4Final prospectus 333-2567730001193125-21-199386
2021-06-23EFFECTDeclared effective 333-2567739999999995-21-002471
2021-06-21S-1/AAmendment 333-2567730001193125-21-194056
2021-06-09S-1/AAmendment 333-2567730001193125-21-186830
2021-06-04S-1Registration filed 333-2567730001193125-21-182268
2021-04-19DRSDraft made public 377-046840000950123-21-004703

All filings of this company · CSV